PCM
CLMT icon

Penserra Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Penserra Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-282
Closed -$1K – 967
2016
Q2 		$1K Hold
282
– – ﹤0.01% 970
2016
Q1 		$3 Sell
282
-398,674
-100% -$5.54M ﹤0.01% 898
2015
Q4 		$7.94M Buy
+398,956
New +$9.86M 0.76% 28

Other funds holding CLMT

RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
SOAMC
Spirit of America Management Corp Syosset, New York $530M AUM 36.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Penserra Capital Management's CLMT Position: Q3 2016 in Review

Penserra Capital Management sold out of Calumet Specialty Products (CLMT) in Q3 2016, closing a stake of 282 shares — an estimated $1K sold.

Penserra Capital Management first reported a position in CLMT in Q4 2015 and held it in 3 quarters. The position peaked at $7.94M in Q4 2015. 93 funds tracked by Wall St. Rank hold CLMT as of Q3 2016.

  • Penserra Capital Management reported no remaining Calumet Specialty Products position as of Q3 2016 after selling out during the quarter.
  • Penserra Capital Management sold 282 Calumet Specialty Products shares in Q3 2016, an estimated $1K.
  • Penserra Capital Management first reported a position in Calumet Specialty Products in Q4 2015 and held it in 3 quarters.
  • Penserra Capital Management's Calumet Specialty Products position peaked at $7.94M in Q4 2015.
  • 93 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2016.

Based on Penserra Capital Management's 13F filing for Q3 2016, filed 3 Nov 2016.